NEW YORK (GenomeWeb News) - Response Genetics today said it has struck an agreement with Hitachi Chemical that will allow Hitachi to use its genetic diagnostic testing methods and services for formalin-fixed paraffin-embedded tissue samples in Southeast Asia, Australia, and New Zealand. 
 
Hitachi will also give Response Genetics access to “potential new testing services customers” in Asia for its FFPE clinical sample testing technology, the company said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.